Tag: LRRK2

LRRK2 Therapy Reports Positive Phase I Findings

Key Takeaways from The Michael J. Fox Foundation’s Virtual LRRK2 Industry Summit

Higher Caffeine Linked to Lower Parkinson’s in LRRK2 Mutation Carriers

New Findings on LRRK2 Show Promise for Everyone Living with Parkinson’s

A ‘Milestone Moment’ for Parkinson’s: LRRK2 drug moves to next stage

LRRK2 Drug Trial Shows Promising Results

Common Link Across Different Causes of Parkinson’s

Another Leap Forward for LRKK2 Development

Glenda Halliday and Nic Dzamko Share their Research in Layman Terms